June 2008
Authors : Eirini I Rigopoulou1,2 , George N Dalekos1,2
Affliation :
†1University of Thessaly, Department of Medicine, Academic Liver Unit and Research Lab of Internal Medicine, Medical School, Papakiriazi 22 Street, 41222 Larissa, Greece ; ; dalekos@med.uth.gr
2Institute of Biomedical Research and Technology, Research Group of Investigational Medicine, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), Larissa, Greece
DOI : 10.1517/17530059.2.6.621
Published in : Expert Opin. Med. Diagn. Volume 2 Issue 6 2008 pages 621 634
Subject:
Keywords: antigp210 antibodies , antimitochondrial antibodies , antinuclear antibodies , anti-PDC-E2 antibodies , antisp100 antibodies , autoimmune cholestatic liver diseases , primary biliary diagnosis
Please Login to read the full article.
- Super failure: What's ahead for health care under automatic $1.2 trillion cuts?
- Agios $78M C round includes public market investors, as firm grows beyond Celgene
- US Capitol Capsule: Republicans press PhRMA for details of closed-door White House health reform powwows
- HGSI, GSK win US FDA OK of Benlysta as first new lupus drug
